NR3C2 and hydrops fetalis: Patients with ATTR-CAappear to respond differently to neurohormonal (NH) blockade withangiotensin-converting enzyme inhibitors (ACEi)/angiotensin receptor blockers(ARBs), beta-blockers, and mineralocorticoid receptor antagonists (MRAs), ascompared with other patients with HF.